nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—CYP2C18—chronic kidney failure	0.395	0.508	CbGaD
Buprenorphine—CYP2C19—chronic kidney failure	0.177	0.228	CbGaD
Buprenorphine—CYP3A4—chronic kidney failure	0.113	0.145	CbGaD
Buprenorphine—ABCB1—chronic kidney failure	0.0938	0.12	CbGaD
Buprenorphine—CYP2C9—cardial valve—chronic kidney failure	0.00747	0.161	CbGeAlD
Buprenorphine—OPRM1—nerve—chronic kidney failure	0.00208	0.0449	CbGeAlD
Buprenorphine—CYP2C19—urine—chronic kidney failure	0.00208	0.0448	CbGeAlD
Buprenorphine—CYP1A2—urine—chronic kidney failure	0.0017	0.0366	CbGeAlD
Buprenorphine—OPRL1—blood—chronic kidney failure	0.00164	0.0354	CbGeAlD
Buprenorphine—CYP2C9—urine—chronic kidney failure	0.00161	0.0347	CbGeAlD
Buprenorphine—UGT1A9—renal system—chronic kidney failure	0.00137	0.0295	CbGeAlD
Buprenorphine—UGT1A9—kidney—chronic kidney failure	0.00132	0.0285	CbGeAlD
Buprenorphine—CYP3A4—urine—chronic kidney failure	0.00123	0.0265	CbGeAlD
Buprenorphine—CYP2D6—urine—chronic kidney failure	0.00121	0.0261	CbGeAlD
Buprenorphine—UGT1A9—digestive system—chronic kidney failure	0.00112	0.0242	CbGeAlD
Buprenorphine—CYP2C19—blood plasma—chronic kidney failure	0.00108	0.0234	CbGeAlD
Buprenorphine—OPRD1—renal system—chronic kidney failure	0.00108	0.0233	CbGeAlD
Buprenorphine—CYP3A7-CYP3A51P—nephron tubule—chronic kidney failure	0.00106	0.023	CbGeAlD
Buprenorphine—OPRD1—kidney—chronic kidney failure	0.00105	0.0225	CbGeAlD
Buprenorphine—CYP2C18—digestive system—chronic kidney failure	0.000981	0.0212	CbGeAlD
Buprenorphine—CYP2C8—blood plasma—chronic kidney failure	0.000946	0.0204	CbGeAlD
Buprenorphine—CYP3A7-CYP3A51P—cortex of kidney—chronic kidney failure	0.000911	0.0196	CbGeAlD
Buprenorphine—CYP1A2—blood plasma—chronic kidney failure	0.000885	0.0191	CbGeAlD
Buprenorphine—CYP3A5—blood plasma—chronic kidney failure	0.000854	0.0184	CbGeAlD
Buprenorphine—CYP2C9—blood plasma—chronic kidney failure	0.00084	0.0181	CbGeAlD
Buprenorphine—CYP3A4—blood plasma—chronic kidney failure	0.000641	0.0138	CbGeAlD
Buprenorphine—CYP2D6—blood plasma—chronic kidney failure	0.000631	0.0136	CbGeAlD
Buprenorphine—OPRM1—blood—chronic kidney failure	0.000576	0.0124	CbGeAlD
Buprenorphine—Oxymorphone—CYP3A4—chronic kidney failure	0.000548	0.263	CrCbGaD
Buprenorphine—ABCG2—nephron tubule—chronic kidney failure	0.000474	0.0102	CbGeAlD
Buprenorphine—Naltrexone—ABCB1—chronic kidney failure	0.000457	0.219	CrCbGaD
Buprenorphine—ABCB1—blood plasma—chronic kidney failure	0.000454	0.00979	CbGeAlD
Buprenorphine—CYP2C8—renal system—chronic kidney failure	0.000444	0.00957	CbGeAlD
Buprenorphine—CYP3A5—nephron tubule—chronic kidney failure	0.00044	0.0095	CbGeAlD
Buprenorphine—CYP2C8—kidney—chronic kidney failure	0.000429	0.00925	CbGeAlD
Buprenorphine—ABCG2—urethra—chronic kidney failure	0.000424	0.00914	CbGeAlD
Buprenorphine—CYP2C19—digestive system—chronic kidney failure	0.000417	0.00899	CbGeAlD
Buprenorphine—CYP1A2—renal system—chronic kidney failure	0.000415	0.00895	CbGeAlD
Buprenorphine—CYP3A5—renal system—chronic kidney failure	0.0004	0.00864	CbGeAlD
Buprenorphine—Naloxone—CYP3A4—chronic kidney failure	0.0004	0.192	CrCbGaD
Buprenorphine—CYP2C19—blood—chronic kidney failure	0.000397	0.00857	CbGeAlD
Buprenorphine—CYP2C9—cardiovascular system—chronic kidney failure	0.000389	0.0084	CbGeAlD
Buprenorphine—CYP3A5—kidney—chronic kidney failure	0.000387	0.00835	CbGeAlD
Buprenorphine—CYP3A5—cortex of kidney—chronic kidney failure	0.000377	0.00813	CbGeAlD
Buprenorphine—Naloxone—ALB—chronic kidney failure	0.000349	0.167	CrCbGaD
Buprenorphine—CYP2C8—blood—chronic kidney failure	0.000347	0.00748	CbGeAlD
Buprenorphine—CYP1A2—digestive system—chronic kidney failure	0.00034	0.00734	CbGeAlD
Buprenorphine—ABCG2—blood—chronic kidney failure	0.000337	0.00727	CbGeAlD
Buprenorphine—Naloxone—ABCB1—chronic kidney failure	0.000333	0.16	CrCbGaD
Buprenorphine—CYP3A5—digestive system—chronic kidney failure	0.000328	0.00708	CbGeAlD
Buprenorphine—CYP1A2—blood—chronic kidney failure	0.000324	0.007	CbGeAlD
Buprenorphine—CYP2C9—digestive system—chronic kidney failure	0.000323	0.00697	CbGeAlD
Buprenorphine—CYP3A5—blood—chronic kidney failure	0.000313	0.00675	CbGeAlD
Buprenorphine—CYP2C9—blood—chronic kidney failure	0.000308	0.00664	CbGeAlD
Buprenorphine—CYP3A4—renal system—chronic kidney failure	0.0003	0.00648	CbGeAlD
Buprenorphine—CYP2D6—renal system—chronic kidney failure	0.000296	0.00638	CbGeAlD
Buprenorphine—CYP3A4—kidney—chronic kidney failure	0.00029	0.00627	CbGeAlD
Buprenorphine—CYP2D6—kidney—chronic kidney failure	0.000286	0.00617	CbGeAlD
Buprenorphine—CYP3A4—digestive system—chronic kidney failure	0.000246	0.00532	CbGeAlD
Buprenorphine—CYP2D6—digestive system—chronic kidney failure	0.000242	0.00523	CbGeAlD
Buprenorphine—CYP3A4—blood—chronic kidney failure	0.000235	0.00506	CbGeAlD
Buprenorphine—ABCB1—nephron tubule—chronic kidney failure	0.000234	0.00505	CbGeAlD
Buprenorphine—CYP2D6—blood—chronic kidney failure	0.000231	0.00498	CbGeAlD
Buprenorphine—ABCB1—renal system—chronic kidney failure	0.000213	0.00459	CbGeAlD
Buprenorphine—ABCB1—cardiovascular system—chronic kidney failure	0.00021	0.00453	CbGeAlD
Buprenorphine—ABCB1—urethra—chronic kidney failure	0.000209	0.00451	CbGeAlD
Buprenorphine—ABCB1—kidney—chronic kidney failure	0.000206	0.00444	CbGeAlD
Buprenorphine—ABCB1—cortex of kidney—chronic kidney failure	0.0002	0.00432	CbGeAlD
Buprenorphine—ABCB1—gonad—chronic kidney failure	0.000191	0.00411	CbGeAlD
Buprenorphine—ABCB1—digestive system—chronic kidney failure	0.000174	0.00376	CbGeAlD
Buprenorphine—ABCB1—blood—chronic kidney failure	0.000166	0.00358	CbGeAlD
Buprenorphine—OPRD1—Signaling Pathways—POMC—chronic kidney failure	8.57e-06	4.96e-05	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—NOS3—chronic kidney failure	8.57e-06	4.96e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	8.57e-06	4.96e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CPT1A—chronic kidney failure	8.52e-06	4.93e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS1—chronic kidney failure	8.51e-06	4.93e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CYP3A4—chronic kidney failure	8.5e-06	4.92e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SREBF2—chronic kidney failure	8.44e-06	4.88e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCL2—chronic kidney failure	8.38e-06	4.85e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	8.37e-06	4.84e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ABCA1—chronic kidney failure	8.36e-06	4.84e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NGF—chronic kidney failure	8.35e-06	4.83e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—SREBF1—chronic kidney failure	8.35e-06	4.83e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CPT1A—chronic kidney failure	8.32e-06	4.81e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—LPL—chronic kidney failure	8.31e-06	4.81e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—LIPC—chronic kidney failure	8.31e-06	4.81e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ABCG1—chronic kidney failure	8.3e-06	4.8e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—F2—chronic kidney failure	8.25e-06	4.77e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IGF1—chronic kidney failure	8.24e-06	4.77e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—MTHFR—chronic kidney failure	8.24e-06	4.77e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	8.2e-06	4.74e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—MTHFR—chronic kidney failure	8.17e-06	4.73e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ABCC3—chronic kidney failure	8.15e-06	4.71e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GCKR—chronic kidney failure	8.15e-06	4.71e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCR5—chronic kidney failure	8.13e-06	4.7e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—HMGCR—chronic kidney failure	8.12e-06	4.7e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	8.12e-06	4.7e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—LIPC—chronic kidney failure	8.11e-06	4.69e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP2C19—chronic kidney failure	8.11e-06	4.69e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PPARA—chronic kidney failure	8.08e-06	4.68e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CYP1A1—chronic kidney failure	8.03e-06	4.65e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PPARA—chronic kidney failure	8.01e-06	4.64e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—LPIN1—chronic kidney failure	7.97e-06	4.61e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ARG2—chronic kidney failure	7.96e-06	4.6e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—FASN—chronic kidney failure	7.95e-06	4.6e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CPT1A—chronic kidney failure	7.84e-06	4.54e-05	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTGS2—chronic kidney failure	7.84e-06	4.54e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	7.83e-06	4.53e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—SERPINE1—chronic kidney failure	7.83e-06	4.53e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP2C18—chronic kidney failure	7.81e-06	4.52e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—LRP2—chronic kidney failure	7.81e-06	4.52e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IRS1—chronic kidney failure	7.8e-06	4.52e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—LCAT—chronic kidney failure	7.8e-06	4.51e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CPT1A—chronic kidney failure	7.77e-06	4.5e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—POMC—chronic kidney failure	7.77e-06	4.49e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—KRAS—chronic kidney failure	7.75e-06	4.48e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—SCARB1—chronic kidney failure	7.68e-06	4.44e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP2C19—chronic kidney failure	7.64e-06	4.42e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—LIPC—chronic kidney failure	7.64e-06	4.42e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS1—chronic kidney failure	7.6e-06	4.4e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—LIPC—chronic kidney failure	7.57e-06	4.38e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP2C19—chronic kidney failure	7.57e-06	4.38e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—POMC—chronic kidney failure	7.51e-06	4.35e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—SCARB1—chronic kidney failure	7.49e-06	4.34e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—MTHFR—chronic kidney failure	7.49e-06	4.33e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	7.47e-06	4.32e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NOS3—chronic kidney failure	7.47e-06	4.32e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	7.47e-06	4.32e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—SREBF1—chronic kidney failure	7.45e-06	4.31e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS1—chronic kidney failure	7.42e-06	4.29e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP3A4—chronic kidney failure	7.36e-06	4.26e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCL2—chronic kidney failure	7.35e-06	4.25e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PPARA—chronic kidney failure	7.34e-06	4.25e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	7.32e-06	4.24e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—SREBF1—chronic kidney failure	7.27e-06	4.21e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—HMGCR—chronic kidney failure	7.25e-06	4.19e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ABCA1—chronic kidney failure	7.24e-06	4.19e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IGF1—chronic kidney failure	7.23e-06	4.18e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—DDC—chronic kidney failure	7.16e-06	4.14e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—FASN—chronic kidney failure	7.09e-06	4.1e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ALB—chronic kidney failure	7.08e-06	4.1e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—HMGCR—chronic kidney failure	7.07e-06	4.09e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CAT—chronic kidney failure	7.07e-06	4.09e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—SCARB1—chronic kidney failure	7.06e-06	4.09e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—RELA—chronic kidney failure	7.03e-06	4.07e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—SCARB1—chronic kidney failure	7e-06	4.05e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS1—chronic kidney failure	6.99e-06	4.04e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—F2—chronic kidney failure	6.97e-06	4.03e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	6.95e-06	4.02e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	6.95e-06	4.02e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PRKD1—chronic kidney failure	6.95e-06	4.02e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—ALB—chronic kidney failure	6.94e-06	4.01e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS1—chronic kidney failure	6.93e-06	4.01e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—FASN—chronic kidney failure	6.92e-06	4.01e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ABCB1—chronic kidney failure	6.88e-06	3.98e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SERPINE1—chronic kidney failure	6.86e-06	3.97e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—SREBF1—chronic kidney failure	6.85e-06	3.97e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	6.81e-06	3.94e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—KRAS—chronic kidney failure	6.79e-06	3.93e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—SREBF1—chronic kidney failure	6.79e-06	3.93e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—NOS3—chronic kidney failure	6.77e-06	3.92e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—HMGCR—chronic kidney failure	6.67e-06	3.86e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CPT1A—chronic kidney failure	6.64e-06	3.84e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—HMGCR—chronic kidney failure	6.61e-06	3.82e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IRS1—chronic kidney failure	6.59e-06	3.82e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—POMC—chronic kidney failure	6.59e-06	3.81e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP3A4—chronic kidney failure	6.57e-06	3.8e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—LPL—chronic kidney failure	6.56e-06	3.79e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NOS3—chronic kidney failure	6.55e-06	3.79e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	6.54e-06	3.78e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—POMC—chronic kidney failure	6.53e-06	3.78e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—FASN—chronic kidney failure	6.52e-06	3.78e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SREBF2—chronic kidney failure	6.51e-06	3.77e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—LIPC—chronic kidney failure	6.47e-06	3.75e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP2C19—chronic kidney failure	6.47e-06	3.75e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—FASN—chronic kidney failure	6.47e-06	3.74e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ABCA1—chronic kidney failure	6.46e-06	3.74e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP3A4—chronic kidney failure	6.41e-06	3.71e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	6.39e-06	3.7e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—POMC—chronic kidney failure	6.35e-06	3.67e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CYP1A1—chronic kidney failure	6.33e-06	3.66e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ABCA1—chronic kidney failure	6.31e-06	3.65e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL6—chronic kidney failure	6.3e-06	3.65e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ABCC3—chronic kidney failure	6.29e-06	3.64e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GCKR—chronic kidney failure	6.29e-06	3.64e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCL2—chronic kidney failure	6.21e-06	3.6e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTGS2—chronic kidney failure	6.2e-06	3.58e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—RELA—chronic kidney failure	6.17e-06	3.57e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—LPIN1—chronic kidney failure	6.15e-06	3.56e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CAT—chronic kidney failure	6.13e-06	3.55e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IGF1—chronic kidney failure	6.11e-06	3.53e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP3A4—chronic kidney failure	6.04e-06	3.5e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	6.03e-06	3.49e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—LRP2—chronic kidney failure	6.03e-06	3.49e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ALB—chronic kidney failure	6.01e-06	3.48e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP3A4—chronic kidney failure	5.99e-06	3.47e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—POMC—chronic kidney failure	5.99e-06	3.46e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SCARB1—chronic kidney failure	5.98e-06	3.46e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	5.96e-06	3.45e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ABCB1—chronic kidney failure	5.96e-06	3.45e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ALB—chronic kidney failure	5.96e-06	3.45e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ABCA1—chronic kidney failure	5.94e-06	3.44e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NFKB1—chronic kidney failure	5.93e-06	3.43e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS1—chronic kidney failure	5.92e-06	3.43e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MTHFR—chronic kidney failure	5.9e-06	3.42e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ABCA1—chronic kidney failure	5.89e-06	3.41e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	5.82e-06	3.37e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SREBF1—chronic kidney failure	5.81e-06	3.36e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SERPINE1—chronic kidney failure	5.8e-06	3.36e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PPARA—chronic kidney failure	5.79e-06	3.35e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—NOS3—chronic kidney failure	5.75e-06	3.33e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—KRAS—chronic kidney failure	5.74e-06	3.32e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—NOS3—chronic kidney failure	5.7e-06	3.3e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—LPL—chronic kidney failure	5.68e-06	3.29e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—HMGCR—chronic kidney failure	5.65e-06	3.27e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NOS3—chronic kidney failure	5.54e-06	3.2e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6—chronic kidney failure	5.53e-06	3.2e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—FASN—chronic kidney failure	5.53e-06	3.2e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP1A1—chronic kidney failure	5.49e-06	3.17e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CAT—chronic kidney failure	5.47e-06	3.16e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ALB—chronic kidney failure	5.46e-06	3.16e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—VEGFA—chronic kidney failure	5.38e-06	3.12e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CAT—chronic kidney failure	5.34e-06	3.09e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ABCB1—chronic kidney failure	5.32e-06	3.08e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGS2—chronic kidney failure	5.26e-06	3.04e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—NOS3—chronic kidney failure	5.22e-06	3.02e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—RELA—chronic kidney failure	5.21e-06	3.02e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGS2—chronic kidney failure	5.21e-06	3.01e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NFKB1—chronic kidney failure	5.2e-06	3.01e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CPT1A—chronic kidney failure	5.13e-06	2.97e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP3A4—chronic kidney failure	5.12e-06	2.96e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MTHFR—chronic kidney failure	5.11e-06	2.96e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	5.09e-06	2.95e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—LPL—chronic kidney failure	5.07e-06	2.93e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ABCA1—chronic kidney failure	5.03e-06	2.91e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CAT—chronic kidney failure	5.03e-06	2.91e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PPARA—chronic kidney failure	5.02e-06	2.9e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	5e-06	2.89e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—LIPC—chronic kidney failure	5e-06	2.89e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CAT—chronic kidney failure	4.99e-06	2.89e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—LPL—chronic kidney failure	4.95e-06	2.86e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TGFB1—chronic kidney failure	4.94e-06	2.86e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP1A1—chronic kidney failure	4.9e-06	2.83e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ABCB1—chronic kidney failure	4.89e-06	2.83e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ABCB1—chronic kidney failure	4.85e-06	2.81e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP1A1—chronic kidney failure	4.78e-06	2.77e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS2—chronic kidney failure	4.78e-06	2.76e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—POMC—chronic kidney failure	4.72e-06	2.73e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—VEGFA—chronic kidney failure	4.72e-06	2.73e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—chronic kidney failure	4.67e-06	2.7e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—LPL—chronic kidney failure	4.66e-06	2.7e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—LPL—chronic kidney failure	4.62e-06	2.67e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SCARB1—chronic kidney failure	4.62e-06	2.67e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—KRAS—chronic kidney failure	4.58e-06	2.65e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS1—chronic kidney failure	4.57e-06	2.64e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MTHFR—chronic kidney failure	4.56e-06	2.64e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP1A1—chronic kidney failure	4.5e-06	2.61e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SREBF1—chronic kidney failure	4.48e-06	2.59e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PPARA—chronic kidney failure	4.48e-06	2.59e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP1A1—chronic kidney failure	4.46e-06	2.58e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MTHFR—chronic kidney failure	4.46e-06	2.58e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NFKB1—chronic kidney failure	4.4e-06	2.54e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PPARA—chronic kidney failure	4.37e-06	2.53e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—HMGCR—chronic kidney failure	4.36e-06	2.52e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TGFB1—chronic kidney failure	4.33e-06	2.51e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ALB—chronic kidney failure	4.3e-06	2.49e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—FASN—chronic kidney failure	4.27e-06	2.47e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CAT—chronic kidney failure	4.26e-06	2.47e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MTHFR—chronic kidney failure	4.2e-06	2.43e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MTHFR—chronic kidney failure	4.16e-06	2.41e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ABCB1—chronic kidney failure	4.15e-06	2.4e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PPARA—chronic kidney failure	4.12e-06	2.38e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—NOS3—chronic kidney failure	4.12e-06	2.38e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—POMC—chronic kidney failure	4.09e-06	2.37e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPARA—chronic kidney failure	4.08e-06	2.36e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—KRAS—chronic kidney failure	4.01e-06	2.32e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—VEGFA—chronic kidney failure	3.99e-06	2.31e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—LPL—chronic kidney failure	3.95e-06	2.29e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ABCA1—chronic kidney failure	3.88e-06	2.25e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP1A1—chronic kidney failure	3.81e-06	2.21e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS2—chronic kidney failure	3.77e-06	2.18e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ALB—chronic kidney failure	3.73e-06	2.16e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—chronic kidney failure	3.72e-06	2.15e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TGFB1—chronic kidney failure	3.66e-06	2.12e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—POMC—chronic kidney failure	3.65e-06	2.11e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—NOS3—chronic kidney failure	3.57e-06	2.06e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—POMC—chronic kidney failure	3.56e-06	2.06e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MTHFR—chronic kidney failure	3.56e-06	2.06e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPARA—chronic kidney failure	3.49e-06	2.02e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—KRAS—chronic kidney failure	3.39e-06	1.96e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—POMC—chronic kidney failure	3.36e-06	1.94e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—POMC—chronic kidney failure	3.33e-06	1.93e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ALB—chronic kidney failure	3.33e-06	1.93e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CAT—chronic kidney failure	3.29e-06	1.9e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—chronic kidney failure	3.27e-06	1.89e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS2—chronic kidney failure	3.26e-06	1.89e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ALB—chronic kidney failure	3.25e-06	1.88e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ABCB1—chronic kidney failure	3.2e-06	1.85e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—NOS3—chronic kidney failure	3.18e-06	1.84e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—NOS3—chronic kidney failure	3.11e-06	1.8e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ALB—chronic kidney failure	3.06e-06	1.77e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—LPL—chronic kidney failure	3.05e-06	1.76e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ALB—chronic kidney failure	3.03e-06	1.76e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	2.94e-06	1.7e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—NOS3—chronic kidney failure	2.93e-06	1.69e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS2—chronic kidney failure	2.91e-06	1.68e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—NOS3—chronic kidney failure	2.9e-06	1.68e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—POMC—chronic kidney failure	2.84e-06	1.65e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS2—chronic kidney failure	2.84e-06	1.64e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—chronic kidney failure	2.76e-06	1.6e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MTHFR—chronic kidney failure	2.74e-06	1.59e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPARA—chronic kidney failure	2.69e-06	1.56e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS2—chronic kidney failure	2.68e-06	1.55e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS2—chronic kidney failure	2.65e-06	1.54e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ALB—chronic kidney failure	2.59e-06	1.5e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NOS3—chronic kidney failure	2.48e-06	1.44e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS2—chronic kidney failure	2.27e-06	1.31e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—POMC—chronic kidney failure	2.2e-06	1.27e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALB—chronic kidney failure	2e-06	1.16e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NOS3—chronic kidney failure	1.91e-06	1.11e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS2—chronic kidney failure	1.75e-06	1.01e-05	CbGpPWpGaD
